Longevity

Biotechnology, Cancer, Cardiology, Featured, Genetics, Longevity, Med Lifestyle, World health
CRISPR-based diagnostic test capable of identifying heart attacks and certain cancer types

A research group has developed a new diagnostic test that improves on current CRISPR-based testing methods and is capable of identifying various diseases. (Credit: Dean Calma, Flickr) Innovation in diagnostic

Diabetes, Diet, Featured, Longevity, Metabolic syndrome, Obesity, Pharmaceuticals, World health
Tirzepatide shown to be effective weight loss drug in phase III clinical trial

A clinical trial assessing the efficacy of tirzepatide showed the drug to be effective in significantly reducing body weight in obese patients when compared to patients who received a placebo

Biotechnology, Cancer, Genetics, Longevity, Med Lifestyle, Medical News, Men's health
New blood test uses circulating tumor DNA to help develop personalized cancer treatments

A novel blood test developed at the Vancouver Prostate Center utilizes the DNA of metastatic cancer to help with developing patient-specific treatment plans. DNA from malignant cells and tumors is

Biotechnology, Cancer, Gastroenterology, Longevity, Med Lifestyle, Medical News, Pharmaceuticals, World health
Cancer drug shows 100% efficacy in clinical trial involving a dozen patients

A clinical trial assessing the efficacy of drug, Dostarlimab, on a subtype of colorectal cancer was shown to be effective in eliminating cancer in all of the trial’s patients. (Credit:

Diabetes, Longevity, Medical News, Metabolic syndrome, Neurocognitive disorders, Neuroscience
Age-related cognitive decline shown to be accelerated by type 2 diabetes

According to a newly published study, age-related cognitive decline occurs at an increased rate of 26% in those with type 2 diabetes (T2D) compared to people without the disease. (Credit:

Biotechnology, Cardiology, Diabetes, Diet, Longevity, Med Lifestyle, Medical News, Metabolic syndrome, World health
Lipodomic analysis identifies new lipid biomarkers for heart disease and type 2 diabetes

Researches from Deutsches Zentrum fuer Diabetesforschung (DZD), have identified new lipid biomarkers for CVD and T2D using lipodomic analysis. The team also found that increasing unsaturated fatty acid intake reduced